Treating Shoulder Degenerative Arthritis in the Young Athlete - Incorporating Shoulder Arthroplasty? (AANA19)-Can You Avoid Metal In The Shoulder_ Injections And Orthobiologics-Dr. Kevin D. Plancher, M.D.

Can You Avoid Metal In The Shoulder_ Injections And Orthobiologics-Dr. Kevin D. Plancher, M.D.

Video Transcription

Video Summary

The speaker discusses osteoarthritis management, emphasizing that 80% of bank cards (likely a metaphor for joints) develop mild arthritis after 13-14 years. Conservative, or rather aggressive, management includes lifestyle changes, NSAIDs, physical therapy, and intraarticular injections like long-acting steroids. Surgical options, such as total shoulder arthroplasty, are chiefly for older, low-demand patients, with challenges around implant longevity in younger individuals. The speaker highlights biological treatments including PRP, stem cells, bone marrow aspirate, and amniotic fluid-derived therapies. Despite promising regenerative potential, current evidence is limited and FDA regulations strict, with some products removed from the market. PRP variations affect inflammation responses, and multiple injections may be needed. Bone marrow aspirate appears safe and somewhat beneficial. Adipose tissue and amniotic fluid products show potential but lack conclusive human studies. The speaker stresses cautious adoption of new treatments, balancing innovation with patient safety, and encourages collaboration among practitioners to improve outcomes.

Asset Caption

Instructional Course Lecture: Treating Shoulder Degenerative Arthritis in the Young Athlete - Incorporating Shoulder Arthroplasty?

Keywords

Osteoarthritis management

Conservative treatment

Surgical intervention

Biological therapies

Regenerative medicine